Disetronic/Ypsomed – over 40 years of success
In 1984, Disetronic was founded by the brothers Willy and Peter Michel, in Burgdorf, Switzerland. The successful company was the first one to introduce a micro insulin pump on the market. Besides its infusion systems, Disetronic specialised in injection systems. In 2003, the co-founder and main shareholder, Willy Michel, sold Disetronic with its infusion business to Roche. However, he kept the injection business. That is how Ypsomed was born. Ever since, Ypsomed has written its own success story. On 22 September 2004, Ypsomed got listed on SIX Swiss Exchange. Meanwhile, Ypsomed is back in the insulin pump business: from 2010 to 2018 as a distributor of the mylife OmniPod by Insulet and since 2016 with its own insulin pump, the mylife YpsoPump.
Co-founder and main shareholder Willy Michel appointed Honorary Chairman of the Ypsomed Group
Willy Michel was a member of the Group Management of Disetronic Holding AG until April 2003 and was non-executive Chairman of the Board of Directors of Ypsomed Holding AG from 2003 to August 2011. From August 2011 to June 2014, Willy Michel was Delegate of the Board of Directors and CEO of Ypsomed Holding AG and the Ypsomed Group. From July 2014 to June 2022, he served as non-executive Chairman of the Board of Directors of Ypsomed Holding AG.
In appreciation and gratitude for his lifelong, entrepreneurial and successful commitment and in recognition of his decades of service as a person with responsibility for Ypsomed and formerly Disetronic, Dr h.c. Willy Michel was appointed Honorary Chairman of the Board of Directors on 17 May 2022. Willy Michel was appointed Honorary Chairman of the Ypsomed Group by the Board of Directors on 17 May 2022, which is not associated with any function in a governing body.
